Security key
04635X102
Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS)
CUSIP: 04635X102
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 57,127,897
- Total 13F shares
- 56,513,523
- Share change
- +1,002,141
- Total reported value
- $622,063,168
- Put/Call ratio
- 22%
- Price per share
- $11.01
- Number of holders
- 102
- Value change
- +$12,380,808
- Number of buys
- 47
- Number of sells
- 47
Report period
Q3 2024
Institutions
102
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 04635X102
Recent filing periods:
Top shareholders of ATXS - Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) as of Q3 2024
As of 30 Sep 2024,
Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,513,523 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Fairmount Funds Management LLC, BlackRock, Inc., VR Adviser, LLC, TCG Crossover Management, LLC, VANGUARD GROUP INC, and MILLENNIUM MANAGEMENT LLC.
This page lists
102
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
100
Q3 2024 holders
102
Holder diff
2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.